Registro:

Referencias:

• Graubert, T.A., Ley, T.J., How do lymphocytes kill tumor cells? (1996) Clin Cancer Res, 2, pp. 785-789
• Nathan, C.F., Secretory products of macrophages (1987) J Clin Invest, 79, pp. 319-326
• Vandernabeele, P., Declercq, W., Beyaert, R., Fiers, W., Two tumor necrosis factor receptors: Structure and function (1995) Trends in Cell Briol, 5, pp. 392-399
• Induction of apoptosis in mature T cells by tumor necrosis factor (1995) Nature, 377, pp. 348-351
• Baron, S., Tyring, S.T., Fleischmann, W.R., Coppenhaver, D.H., Nielsel, D.W., Kumpel, G.R., Stanton, J., Hughes, T.K., The interferons: Mechanisms of action and clinical applications (1991) JAMA, 266 (10), pp. 1375-1383
• Basham, T., Merigan, T.C., Recombinant interferon-γ increases HLA-DR synthesis and expression (1983) J Immunol, 130 (4), pp. 1492-1494
• Tilg, H., New insights into the mechanisms of interferon alfa: An immunoregulatory and anti-inflammatory cytokine (1997) Gastroenterol, 112, pp. 1017-1021
• Stuyf, S., Van Coillie, E., Paemen, L., Put, W., Lenaerts, J.P., Proost, P., Synergistic induction of MCP-1 and -2 by II-1β and interferons in fibroblasts and epitelial cells (1998) J Leuk Biol, 63 (3), pp. 364-372
• Giordano, L., Moldwin, R.L., Downie, P.A., Goldberg, A., Gupta, R., Aithal, N.H., Growth inhibition of B-cell precursor acute lymphoblastic leukaemia cell lines by monocytes: A role for prostaglandin E2 (1997) Leuk Res, 21 (10), pp. 925-932
• Geng, Y., Hellstrand, K., Wennmalm, A., Hanson, G.K., Apoptotic death of human leukaemic cells induced by vascular cells expressing nitric oxide synthase in response to γ-interferon and tumor necrosis factor-α (1996) Cancer Res, 56 (4), pp. 866-874
• Danforth, D.N., Sgagias, M., Tumor necrosis factor a enhances secretion of transforming growth factor β2 in MCF-7 breast cancer cells (1996) Clin Cancer Res, 2, pp. 827-835
• Bay, M.L., Rodelli, F.M., Mahuad, C.V., Morini, J.C., Inhibidores de la blastogénesis esplénica en cultives primarios de un sarcoma de rata (1998) Nuevas Tendencias en Oncología, 7 (1 SUPL). , abstract 8.13
• Voorzanger, N., Touitou, R., García, E., Delecluse, H.-J., Rousset, F., Joab, Y., Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and acts as cooperative growth factors (1996) Cancer Res, 56 (23), pp. 5499-5505
• Ladeda, V., Puricelli, L., Bal De Kier Joffé, E., Factores presentes en el órgano blanco de la metástasis aumentan la sobrevida de células tratadas con quimioterápicos (1998) Nuevas Tendencias en Oncología, 7 (1 SUPL). , Abstract 8.08
• Unanue, E., Allen, P., The basis for the immunoregulatory role of macrophages and other accesory cells (1987) Science, 236, p. 551
• Alfoldy, P., Lemmel, E., Uracz, W., Activation of human monocytes for nitroblue tetrazolium reduction and the suppression of lymphocyte response to mitogens (1979) Clin Exp Immunol, 41, p. 309
• Hedley, D., Currie, G., Monocytes and macrophages in malignant melanoma. Reduction of nitroblue tetrazolium by peripheral blood monocytes (1978) Br J Cancer, 37, p. 747
• García, M., Barañao, R., Fernández, O., Bordenave, R.H., Rumi, L.S., Circulating immune-complexes in breast and lung cancer, before and after chemotherapy (1987) Allergol et Immunopathol, 15, p. 15
• Novellino, P.S., Trejo, Y.G., Fernández, O., Bordenave, R.H., Rumi, L.S., Relación entre la expresión de HLA-DR de superficie y redución del NBT en monocitos de pacientes con cáncer colorrectal (1991) Sangre, 36, pp. 99-103
• Gruner, S., Volk, H., Falck, P., Von Baer, R., The influence of phagocytic stimuli on the expression of HLA-DR antigens; role of reactive oxigen metabolites (1986) Eur J Immunol, 16, p. 212
• Merendino, R., Generation of superoxide anion and candidacidal activity by LPS-treated macrophages from patients affected by neoplasia (1992) J Chemother, 4, p. 35
• Sztein, M.B., Johnson, H.M., Oppenheim, J.J., Regulation of human peripheral blood mononuclear cells DR antigen expression in vitro by lymphokines and recombinant interferons (1984) J Clin Invest, 73, pp. 565-665
• Chadban, S.J., Tesch, G.H., Foti, R., Lan, H.Y., Atkins, R., Nikolic-Paterson, D.J., Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo (1998) Immunol, 94 (1), pp. 72-78
• Koppelman, B., Neefjes, J.J., De Vries, J.E., De Waal-Malefyt, R., Interleukin-10 down-regulates MHC class II alpha-beta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling (1997) Immunity, 7, pp. 861-871
• Huang, M., Sharma, S., Mao, J.T., Dubinett, S.M., Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production (1996) J Immunol, 157 (12), pp. 5512-5520
• Nicocia, G., Garipoli, C., Venza, M., Sottile, A., Pitini, V., Teti, D., Resistance to PGE2 inhibition of PWM-stimulated lymphocytes from neoplasic patients (1998) Clin Immunol Immunopathol, 87 (2), pp. 115-123
• Uracz, W., Stachura, J., Pituch, A., Popiela, T., Zembala, M., The altered expression of MHC-class II determinants on monocytes of cancer patients (1988) Cancer Immunol Immunother, 27, p. 171

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------